Paradromics is developing a fully implantable brain-computer interface for patients with ALS and locked-in syndrome, requiring FDA clearance, payer reimbursement coverage, and clinical adoption to reach the market. The company competed in a category defined by Neuralink's consumer-facing media presence, where clinicians and biotech investors required clinical evidence to take a company seriously. AI search engines were surfacing competitors ahead of Paradromics for key queries, and the company had not yet established a clear position separate from the consumer BCI category.

Developed the competitive positioning strategy that differentiated Paradromics as a clinical-stage neurotechnology platform. Defined the messaging architecture across clinical and investor audiences and owned execution across the website, social media, and YouTube. Built the AEO/GEO and SEO strategy that resulted in Paradromics being described as the "leading developer" and "premier high-bandwidth neurotechnology leader" in AI-generated responses. Created sales enablement for clinical and investor audiences, including the Reimbursement Brief and pitch materials that translated complex engineering benchmarks into clinical outcomes. The work drove a 215% increase in web traffic and a 362% increase in social engagement.

Blue Cross Blue Shield of Alabama faced a perception challenge where core managed care mechanisms, such as narrow networks, prior authorizations, and cost-sharing, were viewed as barriers rather than benefits, eroding engagement and trust in an already transactional category. A single, cohesive brand message was needed to build awareness across Medicare Advantage audiences, small business group plans in Alabama, and young adults seeking comprehensive coverage as they enter the workforce and start families, demanding an emotionally resonant story around BCBS of Alabama's continuum of care and statewide impact.

Contributed to a multi-channel We Cover What Matters campaign. Demand capture included interactive banner ads that functioned as live symptom checkers and doctor-finder tools, capturing high-intent users directly within the ad unit and routing them to the BCBS site. Post-enrollment retention was built into the demand strategy, with messaging that surfaced member benefits, driving plan tool usage and reducing churn. The B2B and broker track positioned the BCBS card as a valuable employee retention asset, giving the sales force third-party proof points to close group plan accounts. The campaign delivered a Net Promoter Score three to four times the national average, making Blue Cross Blue Shield of Alabama the top-ranked Blue Cross plan in the country.

Intermark Group is a full-service advertising and marketing agency with healthcare and financial services clients, competing in a market where demonstrated expertise in behaviorally grounded marketing directly influences client acquisition. The agency had no structured editorial calendar, minimal organic search traction, and no YouTube presence at the start of the engagement. The goal was to build a repeatable content program that would generate consistent inbound demand and reinforce the agency's positioning as a science-backed marketing partner.

Partnered with the Sales, Product and Accounts teams to build a B2B sales pipeline from awareness to acquisition. Led the development and production of social media and YouTube content, SEO optimized blogs and executive communications. Established a monthly webinar series that included promotion, creation of webinar materials, presenting the webinar with the CEO and engaging qualified leads that led to new business. Created sales enablement materials like one-pagers, pitch decks and statement of work (SOW) documents. Grew our inbound marketing capabilities with a 475% increase in organic blog search traffic and 403% YoY growth in YouTube viewership.

Moffitt Cancer Center is a freestanding NCI-designated Comprehensive Cancer Center in Tampa, Florida, operating without the built-in primary care referral networks that most academic medical systems depend on. Despite posting survival rates up to four times the national average for certain cancers, Moffitt was treating approximately 5% of Florida's cancer patients, with affluent patients defaulting to legacy institutions in New York and Boston and nearly 30% arriving with an incorrect diagnosis or staging. A new CEO brought a mandate for bolder brand positioning across symptomatic patients, prevention audiences, researchers, and major donors.

Contributed to a growth strategy anchored in Urgency, building distinct messaging tracks across four commercial audiences. For symptomatic patients, messaging interrupted the default toward out-of-state legacy institutions. For asymptomatic populations, Health Risk Assessment campaigns served as conversion gates, capturing patient data into CRM nurture streams to drive preventive screenings. Developed a physician liaison sales enablement suite to close referral gaps with independent referring physicians, including competitive battlecards that positioned Moffitt's health outcome data against legacy out-of-state institutions, and service-line decks that help guide physician referrals. The resulting campaign delivered a 66.5% year-over-year increase in new patient conversions and a 40% lift in digital engagement.

OhioHealth is a community-based health system in Columbus, Ohio, competing in a cancer care market where Ohio State University's James Cancer Hospital held commanding brand recognition as an academic medical center with built-in research credibility. At the time of the engagement, 52% of OhioHealth's own associates and 83% of surveyed consumers named the James first when thinking about cancer care. The system was simultaneously launching a new Blood and Marrow Transplant inpatient unit, requiring a campaign that could build category credibility while managing the psychological and insurance barriers specific to cancer care in a community health system setting.

Contributed to the Keep Making Plans campaign, positioning OhioHealth's cancer program around life after treatment and adopting a challenger brand stance by leading with emotional impact. Experiential activations met audiences in familiar community settings, reducing the psychological barriers that often deter patients from seeking specialist care. To support the launch of the Blood and Marrow Transplant unit, developed a physician liaison sales enablement suite including referral gap kits that used patient volume data to show independent oncologists exactly where they were sending transplant patients instead of OhioHealth, and competitive battlecards that gave liaisons a direct clinical and emotional narrative. The campaign also extended to employer and payer audiences, providing evidence of OhioHealth's ability to return working-age adults to their daily lives.

Organogenesis's ReNu is a single-injection amniotic suspension allograft administered by orthopedic specialists to provide long-lasting relief for osteoarthritis and joint pain. As a novel biologic treatment, ReNu faced significant healthcare system barriers including coverage restrictions, prior authorization requirements, and step therapy protocols from insurance intermediaries who classified it as experimental. Patients presented an additional behavioral barrier, frequently reporting joint pain but failing to seek treatment when they associated medical intervention with surgical complexity or short-term results.

Contributed to a campaign that positioned ReNu as the straightforward, low-risk path to long-lasting relief. Demand generation focused on a high-intent audience of affluent osteoarthritis patients with household incomes above $100,000 who were actively seeking solutions outside standard insurance coverage. The content strategy mapped demand across the full conversion path: social awareness campaigns and physician FAQ content captured research-phase interest, while retargeting sequences served direct call to action messages. The Physician Finder tool functioned as the primary sales enablement mechanism, routing motivated patients directly to pre-educated orthopedic specialists.